Become Your 2.0 →
Book A Free Discovery Callcognitive & cardiometabolic risk genomics
Genetic Insight For Smarter Long-Term Prevention
Your genetics offer valuable insight into how your biology affects certain patterns of ageing, cardiovascular risk, metabolic dysfunction and cognitive decline. At HUM2N, we believe the true value of genomics lies in expert interpretation, and translating risk intelligence into meaningful action.
The Cognitive & Cardiometabolic Risk Genomics™ assessment is designed to explore clinically relevant genetic pathways that may influence long-term brain health, cardiovascular resilience and metabolic performance.
- Comprehensive Genomic Analysis
- Expert Clinical Interpretation
- Personalised Risk Mitigation Strategy
.jpg)






























what's included
Why Choose Cognitive & Cardiometabolic Risk Genomics™
The Cognitive & Cardiometabolic Risk Genomics™ assessment is designed to explore clinically relevant genetic pathways that may influence long-term brain health, cardiovascular resilience and metabolic performance.
your Pathway
Pricing & Packs
Choose the level of clinical insight and support that best aligns with your health goals.
WHY HUM2N?
Genetic Insight, Expert Interpretation
At HUM2N, we believe the true value of genomics lies in expert interpretation, and translating risk intelligence into meaningful action.
01
Expert Clinical Interpretation
Your results are interpreted by our expert clinical team in the context of your wider health profile, biomarkers and clinical history.
02
UK-Trained Longevity Physicians
Our longevity physicians are UK-trained GPs with experience in conventional medicine, chronic disease management, functional medicine and longevity science.
03
Personalised Risk Mitigation
You will recieve a tailored plan curated around your unique biology, to help reduce modifiable risk and optimise your body's long-term resilience.
04
Identifying Risks & Taking Action
At HUM2N we do not simply identify the risk, we help you act on it through a variety of longevity strategies tailored to your body's needs
Testimonials
Success Validated
HUM2N TEAM
Meet The Experts

Dr Mohammed Enayat
Founder, CEO - MBBS, BSc, MRCGP, PGDip, AFMCP

Dr Mark Menolascino
Certified Medicine Specialist & Functional Medicine Doctor

Dr Sonia Panchal
Consultant Rheumatologist & Functional Medicine Doctor

Dr Reamika West
GP & Functional Medicine Doctor
Frequently asked questions
What does this assessment explore?
The Cognitive & Cardiometabolic Risk Genomics™assessment is designed to explore clinically relevant genetic pathways that may influence long-term brain health, cardiovascular resilience and metabolic performance.
What genes and pathways are analysed?
This includes analysis of genes associated with lipid metabolism & cholesterol handling, cardiovascular risk susceptibility, inflammatory response, insulin sensitivity & metabolic resilience, methylation efficiency, detoxification pathways, neuroplasticity & cognitive resilience, and neurological ageing risk.
Does the assessment include APOE?
For some individuals, this may include analysis of markers such as APOE, alongside wider cognitive and cardiometabolic genetic risk factors.
How are my results interpreted?
Your results are interpreted by our expert clinical team in the context of your wider health profile, biomarkers and clinical history. This is not a consumer DNA report.
What happens after my results?
A personalised risk mitigation strategy is provided, designed to help reduce modifiable risk and optimise long-term resilience. This may include precision nutritional recommendations, lifestyle optimisation strategies, targeted supplementation, methylation support, inflammation reduction strategies, cardiometabolic optimisation, detoxification support and further diagnostic investigation where appropriate.




.webp)

